Texas House Bill HB46

Texas 2025 - 89th Regular

• Filed: 3/14/25
• Out of House Committee: 5/9/25
• Voted on by House: 5/13/25
• Out of Senate Committee: 5/26/25
• Voted on by Senate: 5/27/25
• Governor Action: 6/20/25

Caption

Relating to the medical use of low-THC cannabis under and the administration of the Texas Compassionate-Use Program; requiring registration.

Impact

The bill amends existing statutes in the Health and Safety Code to facilitate the establishment of new dispensing organizations and to govern the licensing process more efficiently. It mandates that the Department of Public Safety and the Health and Human Services Commission implement necessary rules by specific deadlines, ensuring that patients will have access to licensed dispensaries by the set dates. Furthermore, the bill prohibits counties and municipalities from enacting regulations that would restrict the cultivation or dispensing of low-THC cannabis, thereby standardizing access across Texas.

Summary

House Bill 46, relating to the medical use of low-THC cannabis under the Texas Compassionate-Use Program, aims to refine regulations surrounding the prescription and dispensing of low-THC cannabis to eligible patients. This bill stipulates the conditions under which physicians can prescribe low-THC cannabis, detailing the necessary patient diagnoses, dosage limits, and the licensing processes for dispensing organizations. Additionally, it seeks to enhance patient access by ensuring that new dispensing organizations can be licensed in a timely manner, thereby expanding the availability of low-THC cannabis products for Texans in need.

Sentiment

The sentiment around HB46 appears generally positive among medical professionals and advocates for improved patient care, who see it as a progressive step toward addressing the medical needs of patients suffering from serious conditions. However, there exist concerns among some stakeholders regarding the potential for misuse and the overall impact of cannabis-related legislation on community health and safety. The discussions have highlighted a need to balance accessibility with caution effectively.

Contention

Notable points of contention surrounding HB46 include debates regarding the adequacy of safeguards to prevent misuse of the prescribed cannabis and concerns about the health implications for patients. Some legislators expressed fears that expanding access could lead to unintended consequences. The requirement for physicians to provide medical evidence when prescribing cannabis is one measure included to address these concerns. Nonetheless, the bill has faced scrutiny over the potential for quelling local governments' ability to regulate cannabis within their jurisdictions.